| | Parameters | Type 2 diabetes () | OR (95% CI) | | NBP () | HTN () |
| | Age (years) | | 45–55 | 160 (42.2) | 218 (57.7) | 1 | | 55–65 | 182 (27.5) | 479 (72.5) | 1.930 (1.470, 2.533) | | 65–75 | 68 (17.1) | 330 (82.9) | 3.548 (2.522, 4.992) | | ≥75 | 33 (15.6) | 178 (84.4) | 3.852 (2.483, 5.977) |
| | Anthropometric parameters | | Waist circumference (cm) | | <90 M, <85 F | 224 (34.4) | 427 (65.6) | 1 | | ≥90 M, ≥85 F | 207 (22.0) | 736 (78.1) | 1.921 (1.515, 2.435) | | WHR | | <0.90 M, <0.85 F | 138 (33.8) | 270 (66.2) | 1 | | ≥0.90 M, ≥0.85 F | 305 (24.6) | 935 (75.4) | 1.534 (1.185, 1.986) | | BMI (kg/m2) | | <25.0 | 250 (35.0) | 465 (65.0) | 1 | | 25.0–30.0 | 153 (21.2) | 569 (78.8) | 2.294 (1.785, 2.948) | | ≥30.0 | 24 (14.0) | 148 (86.1) | 3.572 (2.230, 5.721) |
| | Metabolic parameters | | HOMA-IR | | <2.8 | 260 (33.0) | 529 (67.1) | 1 | | ≥2.8 | 183 (21.3) | 676 (78.7) | 1.948 (1.540, 2.465) | | HOMA-beta | 39.9 (22.8, 63.7) | 49.8 (30.5, 77.6) | 1.010 (1.006, 1.013) | | FPG (mmol/L) | 7.1 (6.3, 8.2) | 7.2 (6.4, 8.4) | 1.007 (0.960, 1.057) | | PPG (mmol/L) | 13.4 (11.3, 17) | 13.5 (11.4, 17) | 0.996 (0.974, 1.020) | | FINS (mIU/L) | 7.3 (4.7, 11.4) | 9.4 (6.2, 14) | 1.008 (0.998, 1.019) | | HbA1c (%) | 6.3 (5.8, 7.2) | 6.4 (5.9, 7.2) | 1.014 (0.936, 1.098) | | TCH (mmol/L) | | <4.5 | 92 (24.8) | 279 (75.2) | 1 | | ≥4.5 | 351 (27.5) | 925 (72.5) | 0.843 (0.634, 1.121) | | TG (mmol/L) | | <1.7 | 277 (30.3) | 638 (69.7) | 1 | | ≥1.7 | 166 (22.7) | 566 (77.3) | 1.773 (1.396, 2.251) | | HDL-C (mmol/L) | | <1.04 | 39 (24.5) | 120 (75.5) | | | ≥1.04 | 404 (47.8) | 1084 (72.9) | 0.742 (0.500, 1.102) | | LDL-C (mmol/L) | | <2.6 | 149 (27.6) | 391 (72.4) | 1 | | 2.6–3.4 | 172 (26.3) | 482 (73.7) | 1.115 (0.851, 1.461) | | ≥3.4 | 122 (26.9) | 331 (73.1) | 1.104 (0.818, 1.491) | | UA (μmol/L) | | ≤420 M, ≤360 F | 375 (28.7) | 934 (71.4) | 1 | | >420 M, >360 F | 68 (20.1) | 270 (79.9) | 1.474 (1.079, 2.012) |
| | Thyroid function | | FT3 (pmol/L) | 4.9 (4.5, 5.4) | 5.0 (4.5, 5.4) | 1.211 (1.020, 1.437) | | FT4 (pmol/L) | 15.8 (14.4, 17.2) | 15.8 (14.5, 17.4) | 1.019 (0.973, 1.067) | | TSH (mIU/L) | 2.1 (1.4, 3.0) | 2.2 (1.6, 3.1) | 0.995 (0.966, 1.024) |
| | Liver disease | | Without NAFLD | 296 (37.5) | 494 (62.5) | 1 | | With NAFLD | 147 (21.5) | 536 (78.5) | 2.344 (1.736, 3.165) |
|
|
Adjustment of sex, age, smoke, drinking, and family history of hypertension.
Bold values were used to indicate the significant results ().
NBP, normal BP; HTN, hypertension; M, male; F, female; WHR, waist-hip ratio; BMI, body mass index; HOMA-IR, homeostasis model assessment for insulin resistance index; HOMA-beta, homeostasis model assessment for beta cell function; FPG, fasting plasma glucose; PPG, postprandial plasma glucose; FINS, fasting plasma insulin; HbA1c, hemoglobin A1c; TCH, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; and NAFLD, nonalcoholic fatty liver disease.
|
